Immune Checkpoint Inhibitors (ICI) Promote Neutrophil-Platelet Aggregate and NET Formation in Tumor-Bearing Mice

reltecimod (AB103) - Atox Bio

Young Jun Shim1*, Pat Rayman2*, Paul Pavicic2*, Shadi Swaidani, MD, PhD2*, Alok A Khorana, MD3, Marcela Diaz-Montero, PhD2* and Keith R. McCrae, MD1

Nov 4, 2022